Modeling using clinical examination indicators predicts interstitial lung disease among patients with rheumatoid arthritis
Interstitial lung disease (ILD) is a severe extra-articular manifestation of rheumatoid arthritis (RA) that is well-defined as a chronic systemic autoimmune disease. A proportion of patients with RA-associated ILD (RA-ILD) develop pulmonary fibrosis (PF), resulting in poor prognosis and increased li...
Main Authors: | Yao Wang, Wuqi Song, Jing Wu, Zhangming Li, Fengyun Mu, Yang Li, He Huang, Wenliang Zhu, Fengmin Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2017-02-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/3021.pdf |
Similar Items
-
Lung Damage in Rheumatoid Arthritis—A Retrospective Study
by: Georgiana Dinache, et al.
Published: (2022-12-01) -
Identification and validation of mutual hub genes in idiopathic pulmonary fibrosis and rheumatoid arthritis-associated usual interstitial pneumonia
by: Liangyu Chen, et al.
Published: (2024-04-01) -
Progression of radiographic fibrosis in rheumatoid arthritis-associated interstitial lung disease
by: Dandan Chai, et al.
Published: (2023-09-01) -
Periostin Is a Biomarker of Rheumatoid Arthritis-Associated Interstitial Lung Disease
by: Goushi Matama, et al.
Published: (2023-11-01) -
Better Safe than Sorry: Rheumatoid Arthritis, Interstitial Lung Disease, and Medication—A Narrative Review
by: Iulia-Tania Andronache, et al.
Published: (2023-06-01)